Meditor Group Ltd - Q2 2020 holdings

$477 Million is the total value of Meditor Group Ltd's 6 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .

 Value Shares↓ Weighting
EXEL SellEXELIXIS INC$304,864,000
+52.3%
12,841,798
-10.9%
63.94%
-7.2%
ESPR  ESPERION THERAPEUTICS INC$137,502,000
+101.8%
2,679,8350.0%28.84%
+22.9%
ALKS SellALKERMES PLC$14,553,000
+44.8%
750,000
-13.2%
3.05%
-11.8%
INDA  ISHARES MSCI INDIA ETF$9,286,000
+49.2%
320,0000.0%1.95%
-9.1%
EPI  WISDOMTREE INDIA EARNINGS FUND$8,012,000
+53.3%
400,0000.0%1.68%
-6.7%
CLDX SellCELLDEX THERAPEUTICS$2,558,000
+354.4%
196,846
-53.2%
0.54%
+176.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-07-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
EXELIXIS INC43Q4 202388.9%
ALKERMES PLC31Q4 202062.6%
ISHARES MSCI INDIA ETF31Q4 20235.5%
WISDOMTREE INDIA EARNINGS FUND31Q4 20235.5%
ESPERION THERAPEUTICS INC27Q4 202334.4%
VIVUS INC15Q4 201621.3%
CELLDEX THERAPEUTICS14Q2 20202.7%
PROSHARES ULTRAPRO SHORT S&P5004Q4 20173.8%
PROSHARES ULTRASHORT S&P5004Q4 20173.0%
PROSHARES ULTRASHORT S&P 500 ETF3Q3 20190.8%

View Meditor Group Ltd's complete holdings history.

Latest significant ownerships (13-D/G)
Meditor Group Ltd Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
EXELIXIS, INC.April 09, 201915,001,0735.0%
VIVUS INCDecember 19, 20125,002,8965.0%
VIVUS INCMarch 21, 20126,177,5006.3%
VION PHARMACEUTICALS INCFebruary 15, 20085,736,2007.6%
CYPRESS BIOSCIENCE INCSeptember 26, 20071,864,6455.0%
ONYX PHARMACEUTICALS INCSeptember 12, 20072,627,8004.8%
ACUSPHERE INCJuly 26, 20071,839,4214.0%
NOVACEA INCJune 11, 2007800,0003.4%
ATHEROGENICS INCMay 02, 20071,361,8003.5%

View Meditor Group Ltd's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-01-04
SC 13G/A2024-01-03
13F-HR2023-10-31
13F-HR2023-07-25
13F-HR2023-04-10
13F-HR2023-01-05
SC 13G/A2023-01-04
13F-HR2022-11-07
13F-HR2022-07-18
13F-HR2022-04-12

View Meditor Group Ltd's complete filings history.

Compare quarters

Export Meditor Group Ltd's holdings